Detection of enterovirus in the islet cells of patients with type 1 diabetes: what do we learn from immunohistochemistry?

1. Richardson SJ, Leete P, Dhayal S et al (2013) Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas. Diabetologia. doi:10.1007/s00125-013-3094-7

   Google Scholar 

2. Hansson SF, Korsgren S, Ponten F, Korsgren O (2013) Enteroviruses and the pathogenesis of type 1 diabetes revisited: cross-reactivity of enterovirus capsid protein (VP1) antibodies with human mitochondrial proteins. J Pathol 229:719–728

   Article  CAS  PubMed  Google Scholar 

3. Dako (2003) Specification sheet for clone 5-D8/1, code no. M 7064. Available from www.dako.com/uk/download.pdf?objectid=104286003, accessed 29 November 2013

4. Flodstrom M, Maday A, Balakrishna D, Cleary MM, Yoshimura A, Sarvetnick N (2002) Target cell defense prevents the development of diabetes after viral infection. Nat Immunol 3:373–382

   Article  CAS  PubMed  Google Scholar 

5. Flodstrom-Tullberg M, Hultcrantz M, Stotland A et al (2005) RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection. J Immunol 174:1171–1177

   PubMed  Google Scholar 

6. Aida K, Nishida Y, Tanaka S et al (2011) RIG-I- and MDA5-initiated innate immunity linked with adaptive immunity accelerates beta-cell death in fulminant type 1 diabetes. Diabetes 60:884–889

   Article  CAS  PubMed  Google Scholar 

7. Drescher KM, Kono K, Bopegamage S, Carson SD, Tracy S (2004) Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Virology 329:381–394

   Article  CAS  PubMed  Google Scholar 

8. Kobayashi T, Nishida Y, Tanaka S, Aida K (2011) Pathological changes in the pancreas of fulminant type 1 diabetes and slowly progressive insulin-dependent diabetes mellitus (SPIDDM): innate immunity in fulminant type 1 diabetes and SPIDDM. Diabetes Metab Res Rev 27:965–970

   Article  CAS  PubMed  Google Scholar 

9. Bopegamage S, Kovacova J, Vargova A et al (2005) Coxsackie B virus infection of mice: inoculation by the oral route protects the pancreas from damage, but not from infection. J Gen Virol 86:3271–3280

   Article  CAS  PubMed  Google Scholar 

10. Oikarinen M, Tauriainen S, Honkanen T et al (2008) Analysis of pancreas tissue in a child positive for islet cell antibodies. Diabetologia 51:1796–1802

    Article  CAS  PubMed  Google Scholar 

11. Dotta F, Censini S, van Halteren AG et al (2007) Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci U S A 104:5115–5120

    Article  CAS  PubMed Central  PubMed  Google Scholar 

12. Richardson SJ, Leete P, Bone AJ, Foulis AK, Morgan NG (2013) Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1. Diabetologia 56:185–193

    Article  CAS  PubMed  Google Scholar 

13. Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG (2009) The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 52:1143–1151

    Article  CAS  PubMed  Google Scholar 

14. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG (2011) Immunohistochemical analysis of the relationship between islet cell proliferation and the production of the enteroviral capsid protein, VP1, in the islets of patients with recent-onset type 1 diabetes. Diabetologia 54:2417–2420

    Article  CAS  PubMed  Google Scholar 

15. Roivainen M, Klingel K (2009) Role of enteroviruses in the pathogenesis of type 1 diabetes. Diabetologia 52:995–996

    Article  CAS  PubMed  Google Scholar 

Download references